(0.12%) 5 252.75 points
(0.08%) 39 672 points
(0.22%) 18 294 points
(0.42%) $78.59
(0.62%) $2.27
(-1.20%) $2 346.50
(-0.69%) $28.31
(-0.07%) $1 006.50
(-0.05%) $0.928
(0.20%) $10.85
(-0.04%) $0.798
(-1.36%) $91.41
Live Chart Being Loaded With Signals
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions...
Stats | |
---|---|
Today's Volume | 3 461.00 |
Average Volume | 27 839.00 |
Market Cap | 31.34M |
EPS | $0 ( 2024-05-08 ) |
Next earnings date | ( $0 ) 2024-06-25 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.250 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-23 | Franco-yehuda Chen | Buy | 355 000 | Common Stock |
2024-01-23 | Aberman Zami | Buy | 44 100 | Common Stock |
2024-01-23 | Birger Pinhas Doron | Buy | 39 900 | Common Stock |
2024-01-23 | Shemesh-rasmussen Maital | Buy | 38 150 | Common Stock |
2024-01-23 | Yanay Yaky | Buy | 700 000 | Common Stock |
INSIDER POWER |
---|
99.91 |
Last 95 transactions |
Buy: 8 548 074 | Sell: 1 004 814 |
Pluri Inc. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pluri Inc. Financials
Annual | 2023 |
Revenue: | $287 000 |
Gross Profit: | $278 000 (96.86 %) |
EPS: | $-0.770 |
FY | 2023 |
Revenue: | $287 000 |
Gross Profit: | $278 000 (96.86 %) |
EPS: | $-0.770 |
FY | 2022 |
Revenue: | $234 000 |
Gross Profit: | $-41.36M (-17 674.79 %) |
EPS: | $-1.270 |
FY | 2021 |
Revenue: | $0.00 |
Gross Profit: | $0.00 (0.00 %) |
EPS: | $-1.770 |
Financial Reports:
No articles found.
Pluri Inc.
Pluri Inc., a biotechnology company, focuses on the development of placenta-based cell therapy product candidates for the treatment of multiple inflammatory, muscle injuries, and hematologic conditions. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trials for the muscle recovery after surgery for hip fracture; in Phase II clinical trails for the treatment of acute respiratory distress syndrome associated with COVID-19; and in Phase I/II clinical trial for treatment of steroid-refractory graft versus host disease. It also develops PLX-R18 for incomplete hematopoietic recovery following hematopoietic cell transplantation, as well as a solution for the treatment of acute radiation syndrome. The company was formerly known as Pluristem Therapeutics Inc. and changed its name to Pluri Inc. in July 2022. Pluri Inc. was incorporated in 2001 and is based in Haifa, Israel.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators